Ketofur 200 (ketoprofen - 150 + ceftiofur hydrochloride - 50) (Ketofen analog)

Ceftiofur belongs to the group of third-generation cephalosporins. It is active against gram-positive and gram-negative bacteria, including strains producing beta-lactamases, and some anaerobic bacteria: Escherichia coli, Pasteurella haemolytica, Pasteurella multocida, Haemophilus Somnus, Actinobacillus pleuropneumoniae, Haemophilus parasuisocismellis, Salisuochemella parasuisis, Salisemis paraphuisis, Salis hemophilis paraleguis, Salmonis parasiusis, Pleisuoccephis Vulgaris, , Staphylococcus spp., Actynomyces pyogenes, Salmonella typhimurium, Streptococcus agalactiae, S. dysgalactiae, S. bovis, Klebsiella spp., Citrobacter spp., Enterobacter spp., Bacillus spp., Proteus spp., Poromomeromomium fungomomerumoma bomomerumomacteromumum ) The mechanism of action of the antibiotic is to suppress the synthesis of the bacterial cell wall. Ketoprofen - NSAIDs based on propionic acid. It has analgesic, anti-inflammatory and antipyretic effects. The mechanism of action is associated with inhibition of prostaglandin synthesis at the level of cyclooxygenase. In addition, ketoprofen inhibits lipoxygenase, has anti-bradykinin activity, stabilizes lysosomal membranes, and causes a significant inhibition of neutrophil activity. Ketoprofen is a dual inhibitor of inflammation, blocking the action of cyclooxygenase and lipoxygenase and, thus, preventing the formation of prostaglandins and leukotrienes. Ketoprofen is a painkiller that affects the central and peripheral nervous systems. Its effect is the direct suppression of the action of bradykinin, vasodilators and pain mediators.